VistaGen Therapeutics, Inc.
VTGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $63 | $49 | $67 | $75 |
| Short-Term Investments | $14 | $14 | $13 | $14 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $4 | $2 | $1 |
| Total Curr. Assets | $79 | $67 | $82 | $90 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $81 | $69 | $84 | $92 |
| Liabilities | – | – | – | – |
| Payables | $2 | $0 | $1 | $1 |
| Short-Term Debt | $1 | $2 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $3 | $3 | $0 |
| Other Curr. Liab. | $11 | $7 | $9 | $8 |
| Total Curr. Liab. | $14 | $11 | $13 | $10 |
| LT Debt | $1 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $1 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $2 | $2 |
| Total Liabilities | $15 | $12 | $14 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$442 | -$423 | -$408 | -$394 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $508 | $479 | $478 | $475 |
| Total Equity | $66 | $57 | $70 | $81 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $81 | $69 | $84 | $92 |
| Net Debt | -$61 | -$47 | -$66 | -$73 |